FY2015 Earnings Roundup - 2: New Drugs Gain Traction Overseas to Underpin Japan Makers’ Financial Results

Overseas operations have increasingly bolstered the scorecards of Japanese drug makers, especially first-tier companies. In FY2015, Takeda Pharmaceutical and Astellas Pharma pulled in over 60% of their sales outside Japan, while Sumitomo Dainippon Pharma for the first time earned more...read more